日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer

利用新型天然产物抑制剂 Azalomycin F4a 靶向自噬肽酶 ATG4B 治疗晚期胃癌

Lin Zhong #, Bin Yang #, Zhenhua Zhang #, Junfeng Wang, Xiaojuan Wang, Yinfeng Guo, Weifeng Huang, Qianqian Wang, Guodi Cai, Fan Xia, Shengning Zhou, Shuai Ma, Yichu Nie, Jinping Lei, Min Li, Peiqing Liu, Wenbin Deng, Yonghong Liu, Fanghai Han, Junjian Wang

Targeting castration-resistant prostate cancer with a novel ROR γ antagonist elaiophylin

使用新型 ROR γ 拮抗剂 elaiophylin 靶向治疗去势抵抗性前列腺癌

Jianwei Zheng, Junfeng Wang, Qian Wang, Hongye Zou, Hong Wang, Zhenhua Zhang, Jianghe Chen, Qianqian Wang, Panxia Wang, Yueshan Zhao, Jing Lu, Xiaolei Zhang, Songtao Xiang, Haibin Wang, Jinping Lei, Hong-Wu Chen, Peiqing Liu, Yonghong Liu, Fanghai Han, Junjian Wang

New Anti-Cancer Strategy to Suppress Colorectal Cancer Growth Through Inhibition of ATG4B and Lysosome Function

通过抑制 ATG4B 和溶酶体功能来抑制结直肠癌生长的新型抗癌策略

Yuanyuan Fu, Qianqian Gu, Li Luo, Jiecheng Xu, Yuping Luo, Fan Xia, Fanghai Han, Liang Hong, Xiao-Ming Yin, Zhiying Huang, Min Li

Association between CXCR2 and IL-22BP expression indicate a poor outcome for gastric adenocarcinoma progression

CXCR2 与 IL-22BP 表达之间的关联表明胃腺癌进展的结果不佳

Shi Bin Yang, Fanghai Han, Jian Hai Wu, Zhi Zhao, Wenhua Zhan